Back to results
US 11,530,196 B2Granted
Pyrimidine compound acting on EGFR and ERBB2
AssigneeChina Resources Pharmaceutical Holdings Company Limited
InventorsCharles Z. Ding, Lu Zhang, Xile Liu, Lihong Hu, Wen Jiang, Jian Li, Shuhui Chen
Life of this patent
Estimating the term…
Abstract
Disclosed is a pyrimidine compound acting on an EGFR exon 20 insertion mutation and an ERBB2 exon 20 insertion mutation or a pharmaceutically acceptable salt thereof.
Claims7
A compound represented by formula (I) or a pharmaceutically acceptable salt thereof,
- wherein,
- R1 is selected from C1-3 alkyl,
- R2 is selected from H, F, Cl, Br, I, C1-3 alkyl and cyclopropyl.
A compound represented by the following formula or a pharmaceutically acceptable salt thereof,
Dependencies are inferred from the claim text.